scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0740-5472(03)00158-2 |
P698 | PubMed publication ID | 14698799 |
P2093 | author name string | Hannah K Knudsen | |
Paul M Roman | |||
P2860 | cites work | The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields | Q24256434 |
Innovations in treatment for drug abuse: solutions to a public health problem | Q34198644 | ||
Illegal drug use among rural adults: mental health consequences and treatment utilization | Q39451223 | ||
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram | Q39472627 | ||
The value of acupuncture detoxification programs in a substance abuse treatment system. | Q39524037 | ||
One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment | Q39550515 | ||
Rural and urban similarities and differences in private substance abuse treatment centers | Q39677211 | ||
Mission unfulfilled: potholes on the road to mental health parity | Q40796714 | ||
Manualized treatment for substance abusers with personality disorders: dual focus schema therapy | Q43070618 | ||
Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors' behavior. | Q43620003 | ||
Acupuncture for the treatment of cocaine addiction: a randomized controlled trial | Q43832029 | ||
Adoption and implementation of new technologies in substance abuse treatment. | Q44033265 | ||
Substance user treatment program quality: selected topics | Q44103409 | ||
Staff beliefs about addiction treatment | Q47612604 | ||
Muddling through elegantly: finding the proper balance in rationing | Q47779447 | ||
A national study of the substance abuse treatment workforce | Q48025234 | ||
Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusers | Q48611230 | ||
Substance abuse treatment staff: recovery status and approaches to treatment. | Q50875227 | ||
Organizational process: a missing link between research and practice. | Q51961802 | ||
Manual-guided cognitive-behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community. | Q51965851 | ||
A latent variable model of evidence-based quality improvement for substance abuse treatment. | Q51967066 | ||
Recovering substance abuse staff members' beliefs about addiction. | Q52274007 | ||
A social marketing model for disseminating research-based treatments to addictions treatment providers. | Q52276663 | ||
The federal role in drug abuse technology transfer: a history and perspective. | Q53430425 | ||
Absorptive Capacity: A New Perspective on Learning and Innovation | Q56170044 | ||
Organizational Complexity and Innovation: Developing and Testing Multiple Contingency Models | Q56456934 | ||
Predicting closure of private substance abuse treatment facilities | Q57218896 | ||
Counselors in Public and Private Alcoholism and Drug Abuse Treatment Programs | Q58294912 | ||
Program Change and Organizational Properties a Comparative Analysis | Q72346103 | ||
A conceptual framework for transferring research to practice | Q74318938 | ||
Transporting a research-based adolescent drug treatment into practice | Q74318946 | ||
A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventions | Q74614674 | ||
Organizational and professional characteristics predicting external communications in Canadian public health units | Q77151405 | ||
Play therapy and art therapy for substance abuse clients who have a history of incest victimization | Q77815416 | ||
The Adoption of Radical and Incremental Innovations: An Empirical Analysis | Q99301486 | ||
ORGANIZATIONAL INNOVATION: A META-ANALYSIS OF EFFECTS OF DETERMINANTS AND MODERATORS | Q99301494 | ||
P433 | issue | 1 | |
P304 | page(s) | 353-361 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Journal of Substance Abuse Treatment | Q15762042 |
P1476 | title | Modeling the use of innovations in private treatment organizations: the role of absorptive capacity | |
P478 | volume | 26 |
Q36541145 | A Rasch model analysis of evidence-based treatment practices used in the criminal justice system |
Q37193168 | A categorical typology of naltrexone-adopting private substance abuse treatment centers |
Q37642887 | A comparison of how behavioral health organizations utilize training to prepare for health care reform |
Q36539484 | A national survey of substance abuse treatment for juvenile offenders |
Q36321023 | A structural model of treatment program and individual counselor leadership in innovation transfer |
Q35203808 | A systematic review of the psychometric properties of self-report research utilization measures used in healthcare |
Q90210449 | Acquisition of Information About Innovative Practices in Outpatient Mental Health Clinics |
Q35923250 | Adaptability of contingency management in justice settings: survey findings on attitudes toward using rewards |
Q37406433 | Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention |
Q52298463 | Addiction treatment provider attitudes on staff capacity and evidence-based clinical training: results from a national study. |
Q37216771 | Adolescent-only substance abuse treatment: availability and adoption of components of quality |
Q37580421 | Adoption and diffusion of evidence-based addiction medications in substance abuse treatment |
Q34607338 | Adoption and implementation of medications in addiction treatment programs |
Q34543143 | Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S |
Q35129867 | An exploratory study of alternative configurations of governing boards of substance abuse treatment centers |
Q37067963 | Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system |
Q35621950 | Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis |
Q51920239 | Availability of integrated care for co-occurring substance abuse and psychiatric conditions. |
Q36944935 | Community opioid treatment perspectives on contingency management: perceived feasibility, effectiveness, and transportability of social and financial incentives |
Q33966758 | Competing values among criminal justice administrators: The importance of substance abuse treatment |
Q30374904 | Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence. |
Q34222652 | Counselor Attitudes toward the Use of Motivational Incentives in Addiction Treatment |
Q28396690 | Counselor perceptions of organizational factors and innovations training experiences |
Q34076189 | Diffusion of Contingency Management and Attitudes regarding Its Effectiveness and Acceptability |
Q51928186 | Does service diversification enhance organizational survival?: Evidence from the private substance abuse treatment system. |
Q33810987 | Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector |
Q36640365 | Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practices |
Q38754870 | End-of-Life Care Planning in Accountable Care Organizations: Associations with Organizational Characteristics and Capabilities |
Q33617847 | Evidence-based practice implementation: the impact of public versus private sector organization type on organizational support, provider attitudes, and adoption of evidence-based practice |
Q24633657 | Evidence-based practices in addiction treatment: review and recommendations for public policy |
Q35827981 | Evidence-based treatment practices for drug-involved adults in the criminal justice system |
Q34111054 | Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations |
Q47957049 | Factors associated with an evidence-based measure of implementation for the Adolescent Community Reinforcement Approach. |
Q35865698 | HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure |
Q36972481 | Identifying and ranking implicit leadership strategies to promote evidence-based practice implementation in addiction health services |
Q36461870 | Implementation of Electronic Health Records and Entrepreneurial Strategic Orientation in Substance Use Disorder Treatment Organizations. |
Q35713149 | Innovation adoption as facilitated by a change-oriented workplace |
Q36627877 | Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network. |
Q35021468 | Insights from a national survey into why substance abuse treatment units add prevention and outreach services |
Q36322546 | Longitudinal Examination of Medical Staff Utilization in Substance Use Disorder Treatment Organizations |
Q34258997 | Managerial capacity and adoption of culturally competent practices in outpatient substance abuse treatment organizations |
Q34362703 | Measures for Predictors of Innovation Adoption |
Q38988573 | Organizational Factors and Probation Officer Use of Evidence-Based Practices |
Q46743330 | Organizational change in a perinatal treatment setting: integration of clinical practice and policies on tobacco and smoking cessation |
Q35928356 | Organizational characteristics of drug abuse treatment programs for offenders. |
Q35222515 | Organizational characteristics that foster early adoption of cultural and linguistic competence in outpatient substance abuse treatment in the United States |
Q44779101 | Organizational determinants of boundary spanning activity in outpatient substance abuse treatment programmes |
Q34384706 | Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers |
Q51917831 | Perceived impact by administrators of psychiatric emergency services after changes in a state's mental health system. |
Q87158058 | Predictors of the decision to adopt motivational interviewing in community health settings |
Q46198248 | Program and client characteristics as predictors of the availability of social support services in community-based substance abuse treatment programs |
Q37224883 | Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review |
Q36643013 | Rural substance use treatment centers in the United States: an assessment of treatment quality by location |
Q51905425 | Service delivery in substance abuse treatment: reexamining "comprehensive" care. |
Q36766544 | State policy influence on the early diffusion of buprenorphine in community treatment programs |
Q35736844 | Systems antecedents for dissemination and implementation: a review and analysis of measures |
Q36118446 | Taking Effective Treatments to Scale: Organizational Effects on Outcomes of Multisystemic Therapy for Youth with Co-occurring Substance Use. |
Q34766519 | Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users |
Q33622979 | The Place of Adoption in the NIDA Clinical Trials Network |
Q33716545 | The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation |
Q35792939 | The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters |
Q40201753 | The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment |
Q37648682 | Therapist predictors of treatment delivery fidelity in a community-based trial of 12-step facilitation. |
Q35577449 | Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages |
Q34292827 | Total quality management and performance in substance abuse treatment centers |
Q35875486 | Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis |
Q34037035 | What Influences Participation in QI? A Randomized Trial of Addiction Treatment Organizations |
Q36209934 | Workforce diversity in outpatient substance abuse treatment: the role of leaders' characteristics |
Q35508804 | Workforce professionalism in drug treatment services: impact of California's Proposition 36 |
Search more.